ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $558,000 | -9.4% | 381,953 | -12.0% | 0.00% | -100.0% |
| Q4 2016 | $616,000 | -21.7% | 434,153 | -3.4% | 0.00% | 0.0% |
| Q3 2016 | $787,000 | +2.3% | 449,653 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $769,000 | -13.2% | 449,653 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $886,000 | +3.7% | 449,653 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $854,000 | -0.6% | 449,653 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $859,000 | -58.9% | 449,653 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $2,089,000 | +6.2% | 450,133 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,967,000 | +21.3% | 450,133 | -3.7% | 0.00% | +100.0% |
| Q4 2014 | $1,622,000 | -17.2% | 467,433 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $1,959,000 | -28.5% | 467,433 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,739,000 | -7.0% | 467,433 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $2,945,000 | +21.7% | 467,433 | +13.0% | 0.00% | +50.0% |
| Q4 2013 | $2,420,000 | -0.6% | 413,695 | -10.5% | 0.00% | 0.0% |
| Q3 2013 | $2,435,000 | -31.9% | 462,085 | -0.6% | 0.00% | -50.0% |
| Q2 2013 | $3,578,000 | – | 464,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |